TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3.Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2.Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Value Chain Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. GLOBAL TOXICOLOGY DRUG SCREENING MARKET, BY PRODUCT TYPE
6.1. Overview
6.2. Monitoring and logging
6.3. Security
6.4. Storage and continuous integration/continuous deployment
6.5. Management and orchestration
6.6. Networking and data management services
6.7. Others
7. GLOBAL TOXICOLOGY DRUG SCREENING MARKET, BY TEST TYPE
7.1. Overview
7.2. Acute Systemic Toxicity
7.3. Dermal Toxicity
7.4. Carcinogenicity
7.5. Ocular Toxicity
7.6. Genotoxicity
7.7. Neurotoxicity
7.8. Organ-Specific Toxicity
8. GLOBAL TOXICOLOGY DRUG SCREENING MARKET, BY TECHNOLOGY TYPE
8.1. Overview
8.2. High-Throughput Screening
8.3. Genomics
8.4. Transcriptomics
8.5. Toxicogenomics
8.6. Molecular Screening
9. GLOBAL TOXICOLOGY DRUG SCREENING MARKET, BY END USER
9.1. Overview
9.2. Hospitals and Trauma Centers
9.3. Forensic Laboratories
9.4. Diagnostic Laboratories
9.5. Rehabilitation Centers
9.6. Pharmaceutical & Biotechnology Companies
10. GLOBAL TOXICOLOGY DRUG SCREENING MARKET, BY REGION
10.1. Overview
10.1. North America
10.1.1. US
10.1.2. Canada
10.2. Europe
10.2.1. Germany
10.2.2. France
10.2.3. UK
10.2.4. Italy
10.2.5. Spain
10.2.6. Rest of Europe
10.3. Asia-Pacific
10.3.1. China
10.3.2. India
10.3.3. Japan
10.3.4. South Korea
10.3.5. Australia
10.3.6. Rest of Asia-Pacific
10.4. Rest of the World
10.4.1. Middle East
10.4.2. Africa
10.4.3. Latin America
11. COMPETITIVE LANDSCAPE
11.1. Overview
11.2. Competitive Analysis
11.3. Market Share Analysis
11.4. Major Growth Strategy in the Global Toxicology Drug Screening Market,
11.5. Competitive Benchmarking
11.6. Leading Players in Terms of Number of Developments in the Global Toxicology Drug Screening Market,
11.7. Key Developments and Growth Strategies
11.7.1. New Product Launch/Service Deployment
11.7.2. Merger & Acquisitions
11.7.3. Joint Ventures
11.8. Major Players Financial Matrix
11.8.1. Sales & Operating Income, 2023
11.8.2. Major Players R&D Expenditure. 2023
12. COMPANY PROFILES
12.1. Agilent Technologies, Inc.
12.1.1. Company Overview
12.1.2. Financial Overview
12.1.3. Products Offered
12.1.4. Key Developments
12.1.5. SWOT Analysis
12.1.6. Key Strategies
12.2. Covance, Inc.
12.2.1. Company Overview
12.2.2. Financial Overview
12.2.3. Products Offered
12.2.4. Key Developments
12.2.5. SWOT Analysis
12.2.6. Key Strategies
12.3. Bio-Rad Laboratories, Inc.
12.3.1. Company Overview
12.3.2. Financial Overview
12.3.3. Products Offered
12.3.4. Key Developments
12.3.5. SWOT Analysis
12.3.6. Key Strategies
12.4. BioReliance, Inc.
12.4.1. Company Overview
12.4.2. Financial Overview
12.4.3. Products Offered
12.4.4. Key Developments
12.4.5. SWOT Analysis
12.4.6. Key Strategies
12.5. Thermo Fisher Scientific, Inc.
12.5.1. Company Overview
12.5.2. Financial Overview
12.5.3. Products Offered
12.5.4. Key Developments
12.5.5. SWOT Analysis
12.5.6. Key Strategies
12.6. General Electric Company
12.6.1. Company Overview
12.6.2. Financial Overview
12.6.3. Products Offered
12.6.4. Key Developments
12.6.5. SWOT Analysis
12.6.6. Key Strategies
12.7. Eurofins Scientific SE
12.7.1. Company Overview
12.7.2. Financial Overview
12.7.3. Products Offered
12.7.4. Key Developments
12.7.5. SWOT Analysis
12.7.6. Key Strategies
12.8. GE Healthcare
12.8.1. Company Overview
12.8.2. Financial Overview
12.8.3. Products Offered
12.8.4. Key Developments
12.8.5. SWOT Analysis
12.8.6. Key Strategies
12.9. Quest Diagnostics
12.9.1. Company Overview
12.9.2. Financial Overview
12.9.3. Products Offered
12.9.4. Key Developments
12.9.5. SWOT Analysis
12.9.6. Key Strategies
12.10. Alere, Inc.
12.10.1. Company Overview
12.10.2. Financial Overview
12.10.3. Products Offered
12.10.4. Key Developments
12.10.5. SWOT Analysis
12.10.6. Key Strategies
12.11. Enzo Life Sciences, Inc.
12.11.1. Company Overview
12.11.2. Financial Overview
12.11.3. Products Offered
12.11.4. Key Developments
12.11.5. SWOT Analysis
12.11.6. Key Strategies
13. APPENDIX
13.1. References
13.2. Related Reports
LIST OF TABLES
TABLE 1 GLOBAL TOXICOLOGY DRUG SCREENING MARKET, SYNOPSIS, 2019-2032
TABLE 2 GLOBAL TOXICOLOGY DRUG SCREENING MARKET, ESTIMATES & FORECAST, 2019-2032 (USD BILLION)
TABLE 3 GLOBAL TOXICOLOGY DRUG SCREENING MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 4 GLOBAL TOXICOLOGY DRUG SCREENING MARKET, BY TEST TYPE, 2019-2032 (USD BILLION)
TABLE 5 GLOBAL TOXICOLOGY DRUG SCREENING MARKET, BY TECHNOLOGY TYPE, 2019-2032 (USD BILLION)
TABLE 6 GLOBAL TOXICOLOGY DRUG SCREENING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 7 NORTH AMERICA: TOXICOLOGY DRUG SCREENING MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 8 NORTH AMERICA: TOXICOLOGY DRUG SCREENING MARKET, BY TEST TYPE, 2019-2032 (USD BILLION)
TABLE 9 NORTH AMERICA: TOXICOLOGY DRUG SCREENING MARKET, BY TECHNOLOGY TYPE, 2019-2032 (USD BILLION)
TABLE 10 NORTH AMERICA: TOXICOLOGY DRUG SCREENING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 11 US: TOXICOLOGY DRUG SCREENING MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 12 US: TOXICOLOGY DRUG SCREENING MARKET, BY TEST TYPE, 2019-2032 (USD BILLION)
TABLE 13 US: TOXICOLOGY DRUG SCREENING MARKET, BY TECHNOLOGY TYPE, 2019-2032 (USD BILLION)
TABLE 14 US: TOXICOLOGY DRUG SCREENING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 15 CANADA: TOXICOLOGY DRUG SCREENING MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 16 CANADA: TOXICOLOGY DRUG SCREENING MARKET, BY TEST TYPE, 2019-2032 (USD BILLION)
TABLE 17 CANADA: TOXICOLOGY DRUG SCREENING MARKET, BY TECHNOLOGY TYPE, 2019-2032 (USD BILLION)
TABLE 18 CANADA: TOXICOLOGY DRUG SCREENING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 1 EUROPE: TOXICOLOGY DRUG SCREENING MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 2 EUROPE: TOXICOLOGY DRUG SCREENING MARKET, BY TEST TYPE, 2019-2032 (USD BILLION)
TABLE 3 EUROPE: TOXICOLOGY DRUG SCREENING MARKET, BY TECHNOLOGY TYPE, 2019-2032 (USD BILLION)
TABLE 4 EUROPE: TOXICOLOGY DRUG SCREENING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 5 GERMANY: TOXICOLOGY DRUG SCREENING MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 6 GERMANY: TOXICOLOGY DRUG SCREENING MARKET, BY TEST TYPE, 2019-2032 (USD BILLION)
TABLE 7 GERMANY: TOXICOLOGY DRUG SCREENING MARKET, BY TECHNOLOGY TYPE, 2019-2032 (USD BILLION)
TABLE 8 GERMANY: TOXICOLOGY DRUG SCREENING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 9 FRANCE: TOXICOLOGY DRUG SCREENING MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 10 FRANCE: TOXICOLOGY DRUG SCREENING MARKET, BY TEST TYPE, 2019-2032 (USD BILLION)
TABLE 11 FRANCE: TOXICOLOGY DRUG SCREENING MARKET, BY TECHNOLOGY TYPE, 2019-2032 (USD BILLION)
TABLE 12 FRANCE: TOXICOLOGY DRUG SCREENING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 13 ITALY: TOXICOLOGY DRUG SCREENING MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 14 ITALY: TOXICOLOGY DRUG SCREENING MARKET, BY TEST TYPE, 2019-2032 (USD BILLION)
TABLE 15 ITALY: TOXICOLOGY DRUG SCREENING MARKET, BY TECHNOLOGY TYPE, 2019-2032 (USD BILLION)
TABLE 16 ITALY: TOXICOLOGY DRUG SCREENING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 17 SPAIN: TOXICOLOGY DRUG SCREENING MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 18 SPAIN: TOXICOLOGY DRUG SCREENING MARKET, BY TEST TYPE, 2019-2032 (USD BILLION)
TABLE 19 SPAIN: TOXICOLOGY DRUG SCREENING MARKET, BY TECHNOLOGY TYPE, 2019-2032 (USD BILLION)
TABLE 20 SPAIN: TOXICOLOGY DRUG SCREENING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 21 UK: TOXICOLOGY DRUG SCREENING MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 22 UK: TOXICOLOGY DRUG SCREENING MARKET, BY TEST TYPE, 2019-2032 (USD BILLION)
TABLE 23 UK: TOXICOLOGY DRUG SCREENING MARKET, BY TECHNOLOGY TYPE, 2019-2032 (USD BILLION)
TABLE 24 UK: TOXICOLOGY DRUG SCREENING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 25 REST OF EUROPE: TOXICOLOGY DRUG SCREENING MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 26 REST OF EUROPE: TOXICOLOGY DRUG SCREENING MARKET, BY TEST TYPE, 2019-2032 (USD BILLION)
TABLE 27 REST OF EUROPE: TOXICOLOGY DRUG SCREENING MARKET, BY TECHNOLOGY TYPE, 2019-2032 (USD BILLION)
TABLE 28 REST OF EUROPE: TOXICOLOGY DRUG SCREENING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 29 ASIA-PACIFIC: TOXICOLOGY DRUG SCREENING MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 30 ASIA-PACIFIC: TOXICOLOGY DRUG SCREENING MARKET, BY TEST TYPE, 2019-2032 (USD BILLION)
TABLE 31 ASIA-PACIFIC: TOXICOLOGY DRUG SCREENING MARKET, BY TECHNOLOGY TYPE, 2019-2032 (USD BILLION)
TABLE 32 ASIA-PACIFIC: TOXICOLOGY DRUG SCREENING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 33 JAPAN: TOXICOLOGY DRUG SCREENING MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 34 JAPAN: TOXICOLOGY DRUG SCREENING MARKET, BY TEST TYPE, 2019-2032 (USD BILLION)
TABLE 35 JAPAN: TOXICOLOGY DRUG SCREENING MARKET, BY TECHNOLOGY TYPE, 2019-2032 (USD BILLION)
TABLE 36 JAPAN: TOXICOLOGY DRUG SCREENING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 37 CHINA: TOXICOLOGY DRUG SCREENING MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 38 CHINA: TOXICOLOGY DRUG SCREENING MARKET, BY TEST TYPE, 2019-2032 (USD BILLION)
TABLE 39 CHINA: TOXICOLOGY DRUG SCREENING MARKET, BY TECHNOLOGY TYPE, 2019-2032 (USD BILLION)
TABLE 40 CHINA: TOXICOLOGY DRUG SCREENING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 41 INDIA: TOXICOLOGY DRUG SCREENING MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 42 INDIA: TOXICOLOGY DRUG SCREENING MARKET, BY TEST TYPE, 2019-2032 (USD BILLION)
TABLE 43 INDIA: TOXICOLOGY DRUG SCREENING MARKET, BY TECHNOLOGY TYPE, 2019-2032 (USD BILLION)
TABLE 44 INDIA: TOXICOLOGY DRUG SCREENING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 45 AUSTRALIA: TOXICOLOGY DRUG SCREENING MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 46 AUSTRALIA: TOXICOLOGY DRUG SCREENING MARKET, BY TEST TYPE, 2019-2032 (USD BILLION)
TABLE 47 AUSTRALIA: TOXICOLOGY DRUG SCREENING MARKET, BY TECHNOLOGY TYPE, 2019-2032 (USD BILLION)
TABLE 48 AUSTRALIA: TOXICOLOGY DRUG SCREENING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 49 SOUTH KOREA: TOXICOLOGY DRUG SCREENING MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 50 SOUTH KOREA: TOXICOLOGY DRUG SCREENING MARKET, BY TEST TYPE, 2019-2032 (USD BILLION)
TABLE 51 SOUTH KOREA: TOXICOLOGY DRUG SCREENING MARKET, BY TECHNOLOGY TYPE, 2019-2032 (USD BILLION)
TABLE 52 SOUTH KOREA: TOXICOLOGY DRUG SCREENING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 53 REST OF ASIA-PACIFIC: TOXICOLOGY DRUG SCREENING MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 54 REST OF ASIA-PACIFIC: TOXICOLOGY DRUG SCREENING MARKET, BY TEST TYPE, 2019-2032 (USD BILLION)
TABLE 55 REST OF ASIA-PACIFIC: TOXICOLOGY DRUG SCREENING MARKET, BY TECHNOLOGY TYPE, 2019-2032 (USD BILLION)
TABLE 56 REST OF ASIA-PACIFIC: TOXICOLOGY DRUG SCREENING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 57 REST OF THE WORLD: TOXICOLOGY DRUG SCREENING MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 58 REST OF THE WORLD: TOXICOLOGY DRUG SCREENING MARKET, BY TEST TYPE, 2019-2032 (USD BILLION)
TABLE 59 REST OF THE WORLD: TOXICOLOGY DRUG SCREENING MARKET, BY TECHNOLOGY TYPE, 2019-2032 (USD BILLION)
TABLE 60 REST OF THE WORLD: TOXICOLOGY DRUG SCREENING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 61 MIDDLE EAST: TOXICOLOGY DRUG SCREENING MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 62 MIDDLE EAST: TOXICOLOGY DRUG SCREENING MARKET, BY TEST TYPE, 2019-2032 (USD BILLION)
TABLE 63 MIDDLE EAST: TOXICOLOGY DRUG SCREENING MARKET, BY TECHNOLOGY TYPE, 2019-2032 (USD BILLION)
TABLE 64 MIDDLE EAST: TOXICOLOGY DRUG SCREENING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 65 AFRICA: TOXICOLOGY DRUG SCREENING MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 66 AFRICA: TOXICOLOGY DRUG SCREENING MARKET, BY TEST TYPE, 2019-2032 (USD BILLION)
TABLE 67 AFRICA: TOXICOLOGY DRUG SCREENING MARKET, BY TECHNOLOGY TYPE, 2019-2032 (USD BILLION)
TABLE 68 AFRICA: TOXICOLOGY DRUG SCREENING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 69 LATIN AMERICA: TOXICOLOGY DRUG SCREENING MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 70 LATIN AMERICA: TOXICOLOGY DRUG SCREENING MARKET, BY TEST TYPE, 2019-2032 (USD BILLION)
TABLE 71 LATIN AMERICA: TOXICOLOGY DRUG SCREENING MARKET, BY TECHNOLOGY TYPE, 2019-2032 (USD BILLION)
TABLE 72 LATIN AMERICA: TOXICOLOGY DRUG SCREENING MARKET, BY END USER, 2019-2032 (USD BILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL TOXICOLOGY DRUG SCREENING MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL TOXICOLOGY DRUG SCREENING MARKET
FIGURE 4 GLOBAL TOXICOLOGY DRUG SCREENING MARKET, SHARE (%), BY PRODUCT TYPE, 2023
FIGURE 5 GLOBAL TOXICOLOGY DRUG SCREENING MARKET, SHARE (%), BY TEST TYPE, 2023
FIGURE 6 GLOBAL TOXICOLOGY DRUG SCREENING MARKET, SHARE (%), BY TECHNOLOGY TYPE, 2023
FIGURE 7 GLOBAL TOXICOLOGY DRUG SCREENING MARKET, SHARE (%), BY END USER, 2023
FIGURE 8 GLOBAL TOXICOLOGY DRUG SCREENING MARKET, SHARE (%), BY REGION, 2023
FIGURE 9 NORTH AMERICA: TOXICOLOGY DRUG SCREENING MARKET, SHARE (%), BY REGION, 2023
FIGURE 10 EUROPE: TOXICOLOGY DRUG SCREENING MARKET, SHARE (%), BY REGION, 2023
FIGURE 11 ASIA-PACIFIC: TOXICOLOGY DRUG SCREENING MARKET, SHARE (%), BY REGION, 2023
FIGURE 12 REST OF THE WORLD: TOXICOLOGY DRUG SCREENING MARKET, SHARE (%), BY REGION, 2023
FIGURE 13 GLOBAL TOXICOLOGY DRUG SCREENING MARKET: COMPANY SHARE ANALYSIS, 2023 (%)
FIGURE 14 AGILENT TECHNOLOGIES, INC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 15 AGILENT TECHNOLOGIES, INC: SWOT ANALYSIS
FIGURE 16 COVANCE, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 17 COVANCE, INC.: SWOT ANALYSIS
FIGURE 18 BIO-RAD LABORATORIES, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 19 BIO-RAD LABORATORIES, INC.: SWOT ANALYSIS
FIGURE 20 GENERAL ELECTRIC COMPANY: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 21 GENERAL ELECTRIC COMPANY: SWOT ANALYSIS
FIGURE 22 BIORELIANCE, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 23 BIORELIANCE, INC.: SWOT ANALYSIS
FIGURE 24 THERMO FISHER SCIENTIFIC, INC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 25 THERMO FISHER SCIENTIFIC, INC: SWOT ANALYSIS
FIGURE 26 EUROFINS SCIENTIFIC SE: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 27 EUROFINS SCIENTIFIC SE: SWOT ANALYSIS
FIGURE 28 GE HEALTHCARE: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 29 GE HEALTHCARE: SWOT ANALYSIS
FIGURE 30 QUEST DIAGNOSTICS: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 31 QUEST DIAGNOSTICS: SWOT ANALYSIS
FIGURE 32 ALERE, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 33 ALERE, INC.: SWOT ANALYSIS
FIGURE 34 ENZO LIFE SCIENCES, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 35 ENZO LIFE SCIENCES, INC.: SWOT ANALYSIS
